Karachi: A team of the World Federation of Hemophilia visited the state-of-the-art treatment centre operated by the Hemophilia Welfare Society Karachi (HWSK), the only treatment facility in the province.
Dr. Pierre Fontana from Geneva, Hemophilia Treatment Center Switzerland(Establish HTC) came to visit the Hemophilia Treatment Center of HWSK (As an Emerging HTC) for the World Federation of Hemophilia Medical Twining Program Assessment.
The Hemophilia Treatment Centre (HTC) Twinning Program of the WFH Encourages a network of cooperation between hemophilia treatment centers around the world.
Hemophilia treatment centres are categorized by the WFH as either established or emerging, depending on their level of experience. Most often, the established centre is based in a developed country, while the emerging centre is based in a developing country, but there are exceptions.
The objective of the program is to help emerging centres improve hemophilia treatment and diagnosis. The program encourages the transfer of expertise and knowledge between established and emerging hemophilia centres in the areas of diagnosis, treatment, management of complications, and comprehensive care and support. Twinning activities must focus on sustainability and capacity-building.
Dr. Pierre Fontana was accompanied by the World Federation of Hemophilia’s Regional Manager for Middle East Rana Saifi And Dr. Dure Naz Jamal, Secretary SINDH Blood Transfusion Authority Govt. of Sindh. Dr. Dure Naz is also Chairman of the Medical Advisory Board of HWSK.
The guests engaged with dedicated medical team of the centre and met with patients, underscoring their commitment to enhancing hemophilia care in Pakistan.
This visit signifies a pivotal step toward strengthening collaboration and improving treatment standards for individuals with hemophilia and bleeding disorders in our region.
Expressing his gratitude, founder HWSK, CEO Raheel Ahmed termed it as an important milestone in their collaboration with the Geneva Hemophilia Treatment Center (HTC), Switzerland, under the World Federation of Hemophilia’s (WFH) Medical Twinning Program Assessment. Visiting team conducted an insightful SWOT analysis presentation, evaluating our strengths, weaknesses, opportunities, and threats, he added.
This analysis is key to enhancing our hemophilia care services and building sustainable practices for the future. The collaboration between HWSK HTC, as an emerging center, and Geneva HTC, as an established center, provides a unique opportunity to exchange knowledge, expertise, and best practices in diagnosis, treatment, and comprehensive care, Raheel Ahmed further told.
The WFH Twinning Program promotes a network of cooperation, helping emerging HTCs like ours improve patient outcomes, build capacity, and ensure long-term sustainability in hemophilia care. We’re incredibly thankful to be part of this global initiative that fosters growth and learning between countries, he mentioned.
Together, we’re making strides toward better hemophilia treatment in Pakistan, he concluded.